Delek buys share in German properties

Delek will receive NIS 15.2m. in annual rent from the properties, which include space rented by Deutsche Telekom and European retailer Metro.

By DANIEL KENNEMER
January 23, 2006 07:17
delek logo

delek logo 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

A foreign subsidiary of Delek Real Estate bought a 40 percent holding in two German properties, Delek said Sunday, putting the value of its stake at EU36.58 million. The properties are a five-floor office building and a complex including a two-floor retail space and nine-floor office building, both in the Frankfurt area. Delek will receive NIS 15.2m. in annual rent from the properties, which include space rented by Deutsche Telekom and European retailer Metro. Since 93% of the deal was financed with bank loans, the rent represents a 15% yearly yield on the company's own capital invested.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS